Skip to main content
Journal cover image

Long-term outcomes of phenoclusters in severe tricuspid regurgitation.

Publication ,  Journal Article
Rao, VN; Giczewska, A; Chiswell, K; Felker, GM; Wang, A; Glower, DD; Gaca, JG; Parikh, KS; Vemulapalli, S
Published in: Eur Heart J
June 1, 2023

AIMS: Severe tricuspid regurgitation (TR) exhibits high 1-year morbidity and mortality, yet long-term cardiovascular risk overall and by subgroups remains unknown. This study characterizes 5-year outcomes and identifies distinct clinical risk profiles of severe TR. METHODS AND RESULTS: Patients were included from a large US tertiary referral center with new severe TR by echocardiography based on four-category American Society of Echocardiography grading scale between 2007 and 2018. Patients were categorized by TR etiology (with lead present, primary, and secondary) and by supervised recursive partitioning (survival trees) for outcomes of death and the composite of death or heart failure hospitalization. The Kaplan-Meier estimates and Cox regression models were used to evaluate any association by (i) TR etiology and (ii) groups identified by survival trees and outcomes over 5 years. Among 2379 consecutive patients with new severe TR, median age was 70 years, 61% were female, and 40% were black. Event rates (95% confidence interval) were 30.9 (29.0-32.8) events/100 patient-years for death and 49.0 (45.9-52.2) events/100 patient-years for the composite endpoint, with no significant difference by TR etiology. After applying supervised survival tree modeling, two separate groups of four phenoclusters with distinct clinical prognoses were separately identified for death and the composite endpoint. Variables discriminating both outcomes were age, albumin, blood urea nitrogen, right ventricular function, and systolic blood pressure (all P < 0.05). CONCLUSION: Patients with newly identified severe TR have high 5-year risk for death and death or heart failure hospitalization. Partitioning patients using supervised survival tree models, but not TR etiology, discriminated clinical risk. These data aid in identifying relevant subgroups in clinical trials of TR and clinical risk/benefit analysis for TR therapies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

June 1, 2023

Volume

44

Issue

21

Start / End Page

1910 / 1923

Location

England

Related Subject Headings

  • Tricuspid Valve Insufficiency
  • Treatment Outcome
  • Severity of Illness Index
  • Retrospective Studies
  • Prognosis
  • Humans
  • Heart Failure
  • Echocardiography
  • Cardiovascular System & Hematology
  • Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rao, V. N., Giczewska, A., Chiswell, K., Felker, G. M., Wang, A., Glower, D. D., … Vemulapalli, S. (2023). Long-term outcomes of phenoclusters in severe tricuspid regurgitation. Eur Heart J, 44(21), 1910–1923. https://doi.org/10.1093/eurheartj/ehad133
Rao, Vishal N., Anna Giczewska, Karen Chiswell, G Michael Felker, Andrew Wang, Donald D. Glower, Jeffrey G. Gaca, Kishan S. Parikh, and Sreekanth Vemulapalli. “Long-term outcomes of phenoclusters in severe tricuspid regurgitation.Eur Heart J 44, no. 21 (June 1, 2023): 1910–23. https://doi.org/10.1093/eurheartj/ehad133.
Rao VN, Giczewska A, Chiswell K, Felker GM, Wang A, Glower DD, et al. Long-term outcomes of phenoclusters in severe tricuspid regurgitation. Eur Heart J. 2023 Jun 1;44(21):1910–23.
Rao, Vishal N., et al. “Long-term outcomes of phenoclusters in severe tricuspid regurgitation.Eur Heart J, vol. 44, no. 21, June 2023, pp. 1910–23. Pubmed, doi:10.1093/eurheartj/ehad133.
Rao VN, Giczewska A, Chiswell K, Felker GM, Wang A, Glower DD, Gaca JG, Parikh KS, Vemulapalli S. Long-term outcomes of phenoclusters in severe tricuspid regurgitation. Eur Heart J. 2023 Jun 1;44(21):1910–1923.
Journal cover image

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

June 1, 2023

Volume

44

Issue

21

Start / End Page

1910 / 1923

Location

England

Related Subject Headings

  • Tricuspid Valve Insufficiency
  • Treatment Outcome
  • Severity of Illness Index
  • Retrospective Studies
  • Prognosis
  • Humans
  • Heart Failure
  • Echocardiography
  • Cardiovascular System & Hematology
  • Aged